Chiaro MD, Verbeke C. Cystic tumors of the pancreas: Opportunities and risks. World J Gastrointest Pathophysiol 2015; 6(2): 29-32 [PMID: 25977835 DOI: 10.4291/wjgp.v6.i2.29]
Corresponding Author of This Article
Marco Del Chiaro, MD, PhD, FACS, Associate Professor of Surgery, Head of Pancreatic Surgery Unit, Division of Surgery, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institute at Center for Digestive Diseases, Karolinska University Hospital, K53, 14186 Stockholm, Sweden. marco.del.chiaro@ki.se
Research Domain of This Article
Oncology
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastrointest Pathophysiol. May 15, 2015; 6(2): 29-32 Published online May 15, 2015. doi: 10.4291/wjgp.v6.i2.29
Cystic tumors of the pancreas: Opportunities and risks
Marco Del Chiaro, Caroline Verbeke
Marco Del Chiaro, Pancreatic Surgery Unit, Division of Surgery, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institute at Center for Digestive Diseases, Karolinska University Hospital, 14186 Stockholm, Sweden
Caroline Verbeke, Department of Pathology, Institute of Clinical Medicine, University of Oslo, 0316 Oslo, Norway
Caroline Verbeke, Department of Pathology, Karolinska Institute, 14186 Stockholm, Sweden
Author contributions: Del Chiaro M and Verbeke C equally contributed to this paper.
Conflict-of-interest: None.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Marco Del Chiaro, MD, PhD, FACS, Associate Professor of Surgery, Head of Pancreatic Surgery Unit, Division of Surgery, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institute at Center for Digestive Diseases, Karolinska University Hospital, K53, 14186 Stockholm, Sweden. marco.del.chiaro@ki.se
Telephone: +46-8-58580000 Fax: +46-8-58586366
Received: January 18, 2015 Peer-review started: January 20, 2015 First decision: February 7, 2015 Revised: February 21, 2015 Accepted: March 16, 2015 Article in press: March 18, 2015 Published online: May 15, 2015 Processing time: 100 Days and 18.5 Hours
Core Tip
Core tip: The present paper is an editorial focused on the critical problems regarding the management strategy of pancreatic cystic neoplasms (PCNs). Being a pre-cancerous condition in most of the cases, PCNs represent a unique opportunity to prevent pancreatic cancer and to develop preemptive pancreatic surgery programs. However, the lack of predictive factors of the behaviour of these lesions, the low accuracy of pre-operative diagnostics, and the limited knowledge regarding the natural history of those lesions, result in a substantial risk for under- and over-treatment of patients with PCN and represent a high cost factor for the Health Care organization. The paper underscores the critical importance of both the current management of PCNs and the need for future research.
